Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica SpA is an Italian international pharmaceutical company specializing in specialty treatments and rare disease medicines. The company researches, manufactures, and markets cardiovascular drugs, urological treatments, endocrine therapies, and orphan drugs for rare genetic metabolic conditions. Main revenue drivers comprise global commercial sales of specialty prescription pharmaceuticals, rare disease therapies, and active pharmaceutical ingredients. Recordati serves endocrinologists, cardiologists, urologists, hospital networks, and rare disease patients across Europe, the Americas, and Asia. The company holds an established market position in specialty pharmaceuticals and rare disease treatments globally. Headquartered in Milan, Italy, Recordati SpA is listed on the Borsa Italiana.
4 of the funds FundTelligence covers report a position in Recordati Industria Chimica e Farmaceutica.
- Legal name
- Recordati Industria Chimica e Farmaceutica SpA
- Sector
- Health Care
- Country
- Italy
- Funds holding it
- 4
Funds holding Recordati Industria Chimica e Farmaceutica
- Schroder ISF QEP Global Quality — Schroders · 0.05 % (full portfolio disclosed, June 2026)
- Schroder ISF QEP Global Core — Schroders · 0.05 % (full portfolio disclosed, June 2026)
- KLP AksjeEuropa Indeks — KLP · 0.04 % (full portfolio disclosed, June 2026)
- KLP AksjeGlobal Indeks — KLP · 0.0 % (full portfolio disclosed, June 2026)